Overview
- Product nameAnti-Motilin receptor antibodySee all Motilin receptor primary antibodies ...
- DescriptionRabbit polyclonal to Motilin receptor
- Tested applicationsWB, ELISA more details
- Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat - Immunogen
Synthetic peptide derived from the C terminal region of Human Motilin receptor.
- Positive controlHeLa cell extracts.
Properties
- FormLiquid
- Storage instructionsStore at -20°C. Stable for 12 months at -20°C
- Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 49% PBS, 50% Glycerol, 0.88% Sodium chloride
Note: PBS is without Mg2+ and Ca2+ -
Concentration information loading... - PurityImmunogen affinity purified
- Purification notesab129900 is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab129900 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: 1/500 - 1/1000. Predicted molecular weight: 45 kDa. |
| ELISA | ELISA: 1/20000. |
Target
- FunctionReceptor for motilin.
- Tissue specificityExpressed only in thyroid, stomach, and bone marrow.
- Sequence similaritiesBelongs to the G-protein coupled receptor 1 family.
- Cellular localizationCell membrane.
-
Database links
- Entrez Gene: 2862 Human
- Omim: 602885 Human
- SwissProt: O43193 Human
- Unigene: 248126 Human
Target information above from: UniProt accession
O43193
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- G-protein coupled receptor 38 antibodyGPR38 antibodyMLNR antibody
- Motilin receptor antibodyMTLR antibodyMTLR_HUMAN antibodyMTLR1 antibody
see all
References for Anti-Motilin receptor antibody (ab129900)
ab129900 has not yet been referenced specifically in any publications.